Skip to main content
Now MHRA approved in the UK (10 August 2026). Foundayo is prescription only. We do not sell medicines, issue prescriptions or give personal medical advice.

Orforglipron in the UK: availability, price and how to get it

Orforglipron is the generic name of the medicine sold in the UK as Foundayo. This page answers the practical questions: whether it is available here yet, what it costs, who can be prescribed it, and how to buy it without getting caught out.

  • Reviewed by Nick Johnson
  • Last checked 31 August 2026
  • Sources linked throughout

The short answer

Orforglipron is available in the UK now. The MHRA authorised it on 10 August 2026 under the brand name Foundayo, making the UK the first country in Europe to approve it. It is a once-daily tablet, it is prescription only, it is not currently on the NHS, and it is bought privately through registered online pharmacies after a clinical consultation. UK prices currently start from around £90 a month at the lowest dose and rise with the dose you settle at.

Is orforglipron available in the UK?

Yes, and it has been since August 2026. Orforglipron reached the UK before the rest of Europe, which is unusual and worth understanding, because a lot of the material you will find online is written from a United States perspective and describes a different regulatory position and different prices.

The UK product is branded Foundayo. Orforglipron is the active ingredient, in the same way that semaglutide is the ingredient inside Wegovy and tirzepatide is the ingredient inside Mounjaro. If you search for one and find pages about the other, they are the same medicine, and any UK pharmacy dispensing it will be dispensing Foundayo.

How much does orforglipron cost in the UK?

There is no single price. Orforglipron is a private purchase, so every pharmacy sets its own, and the spread between the cheapest and the dearest provider for exactly the same tablets is wider than most people expect. Two things drive the number you actually pay:

  • Your dose. Treatment runs through six strengths, and cost climbs as you move up. A price quoted for the starting strength tells you very little about what you will pay once you settle.
  • What is bundled. Some prices include the consultation and delivery, some do not. A headline that looks lower can end up higher at checkout.

We track both figures continuously: the standard retail price at every dose and the discounted prices after launch offers and codes, each shown as the total cost at checkout with the date we last verified it. If you only read one thing before buying, make it the guide to finding the lowest genuine price, because the cheapest headline and the cheapest year are frequently not the same provider.

Where to buy orforglipron in the UK safely

Orforglipron is prescription only. That means no legitimate UK seller will supply it without a proper clinical assessment, and any site willing to skip that step is breaking the law rather than doing you a favour. The practical route is a General Pharmaceutical Council registered online pharmacy: you complete a medical questionnaire, a prescriber reviews it, and if treatment is appropriate it is dispensed and posted to you.

Before you pay anyone, do the two-minute check. Find the pharmacy's GPhC registration number on its website, look that number up on the official GPhC register, and confirm the registered name and address match the site you are on. Our guide to spotting a fake pharmacy covers the rest of the warning signs, and every provider we list has been through our own verification checks first.

A newly approved weight loss medicine attracts counterfeiters within days. It happened with Mounjaro and with Wegovy, and it is happening here. Treat unusually cheap orforglipron, sales through social media, and anyone offering it without a consultation as red flags rather than bargains.

Who can be prescribed orforglipron in the UK?

The MHRA licensed it for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 alongside at least one weight-related health condition. It is separately licensed to improve blood sugar control in adults with insufficiently controlled type 2 diabetes.

Meeting the BMI threshold is not the same as being suitable for treatment. A prescriber weighs your full medical history, your current medicines and the class warnings before agreeing to anything, and declining is a normal outcome rather than a failure. Our BMI and eligibility guide sets out where the lines fall, including the adjusted thresholds that apply to some ethnic groups.

Is orforglipron on the NHS?

Not at present. MHRA authorisation allows a medicine to be prescribed privately, but NHS availability is a separate decision made by NICE, which assesses cost effectiveness on its own timetable. Until that concludes, orforglipron in the UK is a private prescription only, which is precisely why the price varies so much between pharmacies and why comparing is worth the ten minutes.

How orforglipron differs from the injections

The obvious difference is the format: a daily tablet rather than a weekly injection, with no needles, no sharps bin and no fridge. The less obvious one matters just as much. Orforglipron is a small molecule rather than a peptide, which is why it can be taken at any time of day with no food or water rules, unlike the Wegovy tablet, which requires an empty stomach and a wait before eating.

On results, the published trials put average weight loss lower than tirzepatide's. That trade-off, convenience against maximum effect, is the honest version of the comparison, and it is a conversation for your prescriber rather than a comparison site. We have set out the detail in orforglipron versus Mounjaro and orforglipron versus the Wegovy pill.

What to read next

If you want the medicine explained properly, including how it works and what the ATTAIN trials actually showed, start with what Foundayo is. If you already know all that and just want the numbers, go straight to the price comparison. For dosing, the six-step guide explains why the strength you start on is not the one you budget for.

Sources and references

  1. MHRA authorisation announcement — UK licensing status and approved indications
  2. MHRA Products portal — official product information and patient leaflet
  3. GPhC register of pharmacies — checking a pharmacy is registered before you buy
  4. NICE — NHS availability assessment
  5. MHRA Yellow Card scheme — reporting suspected side effects or suspicious sellers

Reviewed against primary sources. See our editorial policy for how we source and update content.

Nick Johnson Founder and healthcare pricing analyst, Medstack Ltd

Nick founded Monj, iGovy, Ogovy and Dayo to bring honest, checkout-price comparison and provider verification to the UK weight management medicine market. His background is in IT and data, not pharmacy, which is exactly why the sites stay independent: no provider can buy a ranking, and awkward findings get published. Read more about Dayo and the team.